EUVIMEDEUVIMED entdecken
Übersichtsarbeit

A dual approach to glioblastoma treatment with epigenetic reprogramming and neurogenetic modulation

Mustafa Eren Yuncu iD, Berra Bilgin iD, Derin Avci, Ali Karadag iD, Fusun Ozer iD, Cigir Biray Avci iD

Carcinogenesis · 2025

DOI: 10.1093/carcin/bgag008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Carcinogenesis, 2025. Verfasst von Mustafa Eren Yuncu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Izmir City Hospital, Izmir 35540, Turkey. Hauptthemen laut MEDLINE: Glioblastoma, Epigenesis, Genetic, Brain Neoplasms, Cellular Reprogramming. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 85 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma is a highly aggressive primary brain tumour marked by extensive genomic and epigenomic alterations, cellular heterogeneity, and therapeutic resistance. Despite maximal surgical resection followed by chemoradiotherapy, median survival remains approximately 15 months, reflecting the tumour’s invasive behaviour and adaptability. Advances in molecular oncology have revealed two promising therapeutic directions: epigenetic reprogramming and neurogenetic modulation. Glioblastoma exhibits widespread epigenetic dysregulation that disrupts transcriptional control, enhances cellular plasticity, and drives tumour progression. Concurrently, glioma cells aberrantly reactivate developmental programmes, acquiring neural stem cell-like states governed by transcription factors and signalling networks such as SOX2, OLIG2, Notch, and Wnt. These pathways collectively sustain stemness, lineage mimicry, and therapy resistance. This review proposes a focused conceptual framework centred on epigenetic and neurogenetic modulation as two core regulatory layers shaping glioblastoma plasticity and adaptive resistance. We highlight how DNA methylation, histone modifications, and chromatin remodelling contribute to transcriptional dysregulation, and how neurodevelopmental signalling reinforces malignant plasticity. Emerging preclinical and clinical studies combining epigenetic inhibitors with differentiation- or reprogramming-based therapies are discussed. By uniting mechanistic insights from chromatin biology, neurodevelopment, and cancer therapeutics, this integrative conceptual framework offers a structured lens for targeting key vulnerabilities underlying glioblastoma plasticity. The integration of these complementary strategies offers potential to enhance therapeutic responsiveness and improve disease management in this devastating malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaEpigenesis, GeneticBrain NeoplasmsCellular ReprogrammingHumansGene Expression Regulation, NeoplasticAnimalsDNA MethylationSignal Transduction

Stichwörter der Autor:innen

epigenetic therapyglioblastomaglioma stem cellsneurogenetic modulationneuronal reprogramming

Autor:innen und Institutionen

  • Department of Neurosurgery, Izmir City Hospital, Izmir 35540, Turkey.
  • Bahçeşehir College, 50th Year Science & Technology High School, Izmir 35040, Turkey.
  • Department of Neurosurgery, University of Health Sciences, Izmir Faculty of Medicine, Izmir 35540, Turkey.
  • Department of Medical Biology, Faculty of Medicine, Ege University, Izmir 35100, Turkey.

ORCID-Profile: Mustafa Eren Yuncu, Berra Bilgin, Ali Karadag, Fusun Ozer, Cigir Biray Avci

Zitieren

APA

Yuncu, M. E., Bilgin, B., Avci, D., Karadag, A., Ozer, F., & Biray Avci, C. (2025). A dual approach to glioblastoma treatment with epigenetic reprogramming and neurogenetic modulation. Carcinogenesis. https://doi.org/10.1093/carcin/bgag008

Vancouver

Yuncu ME, Bilgin B, Avci D, Karadag A, Ozer F, Biray Avci C. A dual approach to glioblastoma treatment with epigenetic reprogramming and neurogenetic modulation. Carcinogenesis. 2025. doi:10.1093/carcin/bgag008

BibTeX
@article{Yuncu2025,
  author = {Yuncu, Mustafa Eren and Bilgin, Berra and Avci, Derin and Karadag, Ali and Ozer, Fusun and Biray Avci, Cigir},
  title = {A dual approach to glioblastoma treatment with epigenetic reprogramming and neurogenetic modulation},
  journal = {Carcinogenesis},
  year = {2025},
  doi = {10.1093/carcin/bgag008}
}
Kostenlos starten →